• 2019
  Said Halidi KN, Fontan E, Boucharlat A, Davignon L, Charpentier M, Boullé M, Weil R, Israël A, Laplantine E, Agou F., Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis., iScience. 2019 Sep 25;20:292-309.
• 2017
  Bal E, Laplantine E, Hamel Y, Dubosclard V, Boisson B, Pescatore A, Picard C, Hadj-Rabia S, Royer G, Steffann J, Bonnefont JP, Ursini VM, Vabres P, Munnich A, Casanova JL, Bodemer C, Weil R, Agou F, Smahi A, Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti., J Allergy Clin Immunol. 2017 Dec;140(6):1671-1682.e2.
• 2016
  Scholefield J, Henriques R, Savulescu AF, Fontan E, Boucharlat A, Laplantine E, Smahi A, Israël A, Agou F* and Mhlanga MM*., Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti, Nat Commun. 2016 Sep 2;7:12629.
• 2015
  Agou F, Véron M, In vivo protein cross-linking, Methods Mol. Biol. 2015;1278:391-405.
• 2015
  Dubosclard V, Fontan E, Agou F, Use of fluorescence spectroscopy for quantitative investigations of ubiquitin interactions with the ubiquitin-binding domains of NEMO, Methods Mol. Biol. 2015;1280:321-37.
• 2014
  Tarantino N, Tinevez JY, Crowell EF, Boisson B, Henriques R, Mhlanga M, Agou F, Israël A, Laplantine E, TNF and IL-1 exhibit distinct ubiquitin requirements for inducing NEMO-IKK supramolecular structures, J. Cell Biol. 2014 Jan;204(2):231-45.
• 2013
  Ngadjeua F, Chiaravalli J, Traincard F, Raynal B, Fontan E, Agou F, Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome, J. Biol. Chem. 2013 Nov;288(47):33722-37.
• 2011
  Chiaravalli J, Fontan E, Fsihi H, Coic YM, Baleux F, Véron M, Agou F, Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO, Biochem. Pharmacol. 2011 Nov;82(9):1163-74.
• 2011
  Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S, Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution, Antivir. Ther. (Lond.) 2011;16(4):597-603.
• 2009
  Grubisha O, Kaminska M, Duquerroy S, Fontan E, Cordier F, Haouz A, Raynal B, Chiaravalli J, Delepierre M, Israël A, Véron M, Agou F, DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding, J. Mol. Biol. 2010 Jan;395(1):89-104.
• 2008
  Cordier F, Grubisha O, Traincard F, Véron M, Delepierre M, Agou F, The zinc finger of NEMO is a functional ubiquitin-binding domain, J. Biol. Chem. 2009 Jan;284(5):2902-7.
• 2008
  Cordier F, Vinolo E, Véron M, Delepierre M, Agou F, Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation, J. Mol. Biol. 2008 Apr;377(5):1419-32.
• 2007
  Wyler E, Kaminska M, Coïc YM, Baleux F, Véron M, Agou F, Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO, Protein Sci. 2007 Sep;16(9):2013-22.
• 2007
  Fontan E, Traincard F, Levy SG, Yamaoka S, Véron M, Agou F, NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex, FEBS J. 2007 May;274(10):2540-51.
• 2004
  Agou F, Traincard F, Vinolo E, Courtois G, Yamaoka S, Israël A, Véron M, The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains, J. Biol. Chem. 2004 Jul;279(27):27861-9.
• 2004
  Agou F, Ye F, Véron M, In vivo protein cross-linking, Methods Mol. Biol. 2004;261:427-42.